ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News

Finland Detects African Swine Fever for First Time

Finland has detected African swine fever for the first time after ⁠laboratory tests found the virus in three wild boar piglets in eastern Finland, ⁠the Finnish Food...

Congo's Ebola Outbreak Started At Least in January, Report Shows

Democratic Republic of Congo's fast-spreading Ebola outbreak started in January, or even earlier, in the ⁠eastern Ituri province, a report published in the journal Science...

Escalating Crohn’s Care: The Case for Dual Therapy

Dr Dana Lukin outlines patient selection for combination therapy in Crohn’s disease and highlights the most promising dual-targeted strategies.

Trump Administration Unfreezes $600 Million for Gavi for Global Vaccine Effort

The Trump administration said on Wednesday it will immediately release $600 million in congressionally appropriated funds for vaccines for ⁠the world's poorest countries...

Cyclosporiasis Cases in Michigan Surpass 10,000 in Ongoing Outbreak

Michigan health officials reported 10,077 cases of cyclosporiasis on Wednesday, an increase of 397 ⁠cases since their last update a day earlier.

IGRA vs TST: Which Test Better Detects Latent Tuberculosis?

Tuberculin skin test positivity exceeds interferon-gamma release assay positivity among healthcare workers and first responders, a meta-analysis finds.

Todays Updates

Is Shorter Radiation Linked to Lymphedema in Breast Cancer?

A trial tests whether 40Gy in 15 fractions over 3 weeks leads to more arm lymphedema than 50Gy in 25 fractions over 5 weeks.

Breast Density Laws Fall Short Raising Additional Screening

State mandates requiring insurance coverage for additional breast cancer scans for those with dense breasts are failing to boost usage.

Todays Updates

Is Shorter Radiation Linked to Lymphedema in Breast Cancer?

A trial tests whether 40Gy in 15 fractions over 3 weeks leads to more arm lymphedema than 50Gy in 25 fractions over 5 weeks.

Breast Density Laws Fall Short Raising Additional Screening

State mandates requiring insurance coverage for additional breast cancer scans for those with dense breasts are failing to boost usage.

Latest News

Finland has detected African swine fever for the first time after ⁠laboratory tests found the virus in three wild boar piglets in eastern Finland, ⁠the Finnish Food...

Democratic Republic of Congo's fast-spreading Ebola outbreak started in January, or even earlier, in the ⁠eastern Ituri province, a report published in the journal Science...

Dr Dana Lukin outlines patient selection for combination therapy in Crohn’s disease and highlights the most promising dual-targeted strategies.

The Trump administration said on Wednesday it will immediately release $600 million in congressionally appropriated funds for vaccines for ⁠the world's poorest countries...

Michigan health officials reported 10,077 cases of cyclosporiasis on Wednesday, an increase of 397 ⁠cases since their last update a day earlier.

Tuberculin skin test positivity exceeds interferon-gamma release assay positivity among healthcare workers and first responders, a meta-analysis finds.

News All Time

Pfizer's Prostate Cancer Drug Combination Gets US FDA Priority Review

Pfizer said on Wednesday the U.S. Food and Drug Administration had granted priority review to ⁠its application seeking expanded approval for its prostate cancer treatment...

Proton Pump Inhibitors Boost Exacerbations in Bronchiectasis

Consider a deprescribing trial in patients without chronic indications.

Expected Practice Guidelines Boost Oral/IV Antibiotic Use

Expected practice guidelines increase oral or long-acting intravenous antibiotic use and lower readmission rates, study shows.

Carl H. June on CAR-T’s Next Frontier: Autoimmune Disease

In an interview, Carl H. June discusses how CAR-T therapy transformed blood cancer treatment, the challenges of extending it to solid tumors, and why autoimmune disease may be its next major frontier.

US Cyclosporiasis Cases Top 4,100 as CDC Investigates Lettuce-linked Outbreak

The Centers for Disease Control and Prevention has pegged the number of domestically acquired, lab-confirmed U.S. cyclosporiasis cases ⁠since May 1 at 4,173 after federal...

Congo Says Nearly 1,000 Die Of Ebola, Confirmed Cases Rise to 2,473

The ⁠number of confirmed Ebola ⁠cases in the ⁠Democratic Republic ‌of Congo has increased to 2,473, including ‌999 deaths, government data showed ‌on...

Kids Born in Lockdown Show Lower Executive Function at Age 4

Kids born in the first COVID lockdown in England show age-appropriate language and motor skills, but executive function remains the key area of concern at age 4 and may need extra support at school.

Cyclosporiasis Cases in Michigan Climb to Over 7,000, State Health Officials Say

Michigan health officials reported 7,171 cases linked to an outbreak of cyclosporiasis on Wednesday, up 600 cases since its ⁠last update on Tuesday.

Gilead, Merck Weekly HIV Pill Keeps Virus Suppressed in Late-stage Trials

Gilead Sciences and Merck said on Tuesday their experimental once-weekly HIV pill kept the virus suppressed in ⁠two late-stage trials, supporting regulatory filings for what...

Fewer Children Got US-backed HIV Treatment After Aid Cuts, Study Finds

(Refiles to add missing byline)

Cyclosporiasis Surge: A Clinician's Quick Guide

With a 34-state Cyclospora outbreak driving GI visits, Dr Levy breaks down diagnosis, testing pitfalls, and treatment clinicians need to know.

US FDA Says False-positive Lettuce Test Doesn't Change Taylor Farms Cyclospora Probe

The U.S. Food and Drug Administration on Monday defended publicizing a lettuce sample later found to be ⁠a false positive for cyclospora, saying the reversal does not...

What Has Made the Cyclospora Behind the US Outbreak So Challenging to Trace?

Cyclospora, the parasite behind thousands of suspected U.S. cases of a foodborne illness, has a long incubation period, and samples cannot be cultured in labs, making it...

Japanese Drugmaker Takeda's Qdenga Becomes First Dengue Vaccine Approved in India

Takeda Pharmaceutical's dengue vaccine Qdenga has been approved by India's drug regulator, making it the first such vaccine to be cleared in the country, the Japanese...

India's Serum Institute Partners With Gates MRI to Make Experimental TB Vaccine

(Corrects to fix typo in the headline)

New Zealand Confirms First H5N1 Bird Flu Case in Native Bird

New Zealand detected on Friday the first infection of a native bird ⁠by the deadly H5N1 bird flu, days after confirming a migratory seabird had tested ⁠positive in the...

Recommended News For You

finding fresh approaches to treating diffuse midline gliomas.

Toxic fungus from King Tutankhamun's tomb yields cancer-fighting compounds—new study

Where Did This Very Painful Gluteal Mass Come From?

Massachusetts nurses with brain tumors: Department of Public Health 'in communication' with Newton-Wellesley

Breast cancer surgery: Study finds overnight hospital stay not important for older patients

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

Food insecurity linked to tumor growth in pediatric neuroblastoma

Recommended Articles For You

All About Ferric Gluconate – The Best Source Of Iron For Anemia 

Immune Microenvironment Biomarkers for Early Tumor Evolution 

Decoding Efficacy, Safety, and Future Frontiers in CAR-T Cell Therapy for Hematologic Malignancies Towards CAR-T Therapy 2025 

The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

2.

Early PET May Help Tailor Therapy in Hodgkin Lymphoma

3.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

4.

When Should Immunocompromised Individuals Receive a COVID Booster?

5.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

1.

Artificial Intelligence for Modeling Tumor Ecosystem Dynamics

2.

Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology

3.

Sound Waves and Self-Destruction: A Promising Nanotech Weapon in the Fight Against Cancer

4.

The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia

5.

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

3.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

4.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot